Why I’m watching the Centrica share price closely now

Centrica’s share price is rising finally, but is it reason to buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Centrica (LSE: CNA) share price had a good run this past week, breaking past the 80p mark for the first time in four months after it released a somewhat upbeat trading update. This is very good news for the FTSE 100 share, which has been struggling for a while.

But I believe that it will take more than a single trading update to lift the share price meaningfully, especially after seeing how much it has fallen over the years. To put it in context, the CNA share price has lost over half its value from five years ago. It’s also at a fraction of the highs it has seen over the decade.

No capital gains here

The loss in value was one of my biggest concerns when I first wrote about CNA in May this year. For investors like me, who invest for capital gains, Centrica’s trend isn’t comforting at all. It is one of the reasons why I decided at the time that it was a better idea to hold off from investing in CNA and put it on my ‘wait and watch’ list instead.

Make no mistake, this latest spike in price is a movement in the right direction for the energy supplier. Nevertheless, the share price is a whole 13% lower than when I first talked about it.

Certainly, I wouldn’t buy Centrica shares right now, and I won’t until it has shown some consistent upward price movements. The key question is, to my mind, whether to even keep it on the ‘wait and watch’ list. To me, that depends on how it’s performing right now and how it’s expected to perform going forward.

Promise of better times

The latest trading update contains a few positives about the business, like growth in total customer accounts, higher margins and…. acceleration of cost efficiency delivery”. It also reports that CNA is on track to achieve full-year targets. A case to made for the stock, if a good dividend yield makes you tick. For me, Centrica is still on my ‘wait and watch’ list.

But while we are waiting and watching, may I suggest some shares that are far more predictable in their share price trajectory? Unilever is one I like, because it has given huge capital gains in the past. It’s also a defensive share, being in the business of consumer staples. I have been focusing on this segment in the past days as macroeconomic uncertainty persists.

With its big presence across international markets, Brexit (or the more-likely Brexit limbo) isn’t about to rock its fortunes. Unilever’s share price has also fallen in November so far, making now a good time to invest in this high-quality share.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

With P/E ratios below 8, I think these FTSE 250 shares are bargains!

The forward P/E ratios on these FTSE 250 shares are far below the index average of 14.1 times. I think…

Read more »

Investing Articles

Are stocks and shares the only way to become an ISA millionaire?

With Cash ISAs offering 5%, do stocks and shares make sense at the moment? Over the longer term, Stephen Wright…

Read more »

Dividend Shares

4,775 shares in this dividend stock could yield me £1.6k a year in passive income

Jon Smith explains how he can build passive income from dividend payers via regular investing that can compound quickly.

Read more »

Investing Articles

Is the Rolls-Royce share price heading to 655p? This analyst thinks so

While the Rolls-Royce share price continues to thrash the FTSE 100, this writer has a couple of things on his…

Read more »

Investing Articles

What’s going on with the National Grid share price now?

Volatility continues for the National Grid share price. Is this a warning sign for investors to heed or a buying…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
US Stock

This is a huge week for Nvidia stock

It’s a make-or-break week for Nvidia stock as the company is posting its Q3 earnings on Wednesday. Here’s what investors…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

After crashing 50% this FTSE value stock looks filthy cheap with a P/E of just 9.1%

Harvey Jones has some unfinished business with this FTSE 100 value stock, which he reckons has been harshly treated by…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing For Beginners

Up 40% in a month, what’s going on with the Burberry share price?

Jon Smith points out two key catalysts for the move higher in the Burberry share price, but questions whether anything…

Read more »